These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16533228)

  • 1. Extracutaneous transformation into a high-grade lymphoma: a potential pitfall in the management of patients with Sézary syndrome.
    Michaelis S; Kazakov DV; Burg G; Dummer R; Kempf W
    Int J Dermatol; 2006 Mar; 45(3):277-9. PubMed ID: 16533228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
    Pai RK; Mullins FM; Kim YH; Kong CS
    Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD25+ folliculotropic Sézary syndrome with CD30+ large cell transformation.
    Jang MS; Kang DY; Han SH; Park JB; Kim ST; Suh KS
    Australas J Dermatol; 2014 Feb; 55(1):e4-8. PubMed ID: 23190349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric DNA ploidy analysis of peripheral blood from patients with sezary syndrome: detection of aneuploid neoplastic T cells in the blood is associated with large cell transformation in tissue.
    Wang S; Li N; Heald P; Fisk JM; Fadare O; Howe JG; McNiff JM; Smith BR
    Am J Clin Pathol; 2004 Nov; 122(5):774-82. PubMed ID: 15491974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
    López-Lerma I; Estrach MT
    J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
    Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
    J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin receptor scintigraphy in primary cutaneous T- and B-cell lymphomas.
    Valencak J; Trautinger F; Raderer M; Chott A; Der-Petrossian M; Ivancic-Brandenberger E; Knobler R; Kurtaran A; Hoffmann M
    J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):13-7. PubMed ID: 19515078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinctive phorbol ester-induced morphological and surface antigen changes in mycosis fungoides, the Sézary syndrome, and adult T-cell leukemia.
    Kadin ME; Nasu K; Sako D; Su IJ
    Cancer Res; 1984 Aug; 44(8):3383-7. PubMed ID: 6611200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
    Vidulich KA; Talpur R; Bassett RL; Duvic M
    Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bexarotene treatment of late-stage mycosis fungoides and Sézary syndrome: development of extracutaneous lymphoma in 6 patients.
    Bouwhuis SA; Davis MD; el-Azhary RA; McEvoy MT; Gibson LE; Knudsen JM; Kist JM; Pittelkow MR
    J Am Acad Dermatol; 2005 Jun; 52(6):991-6. PubMed ID: 15928617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cutaneous small/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome.
    Garcia-Herrera A; Colomo L; Camós M; Carreras J; Balague O; Martinez A; Lopéz-Guillermo A; Estrach T; Campo E
    J Clin Oncol; 2008 Jul; 26(20):3364-71. PubMed ID: 18541895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and prediction of prognosis by the CTCL Severity Index in mycosis fungoides and Sézary syndrome.
    Klemke CD; Mansmann U; Poenitz N; Dippel E; Goerdt S
    Br J Dermatol; 2005 Jul; 153(1):118-24. PubMed ID: 16029336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of CD30+ nasal natural killer/T-cell lymphoma.
    Ferenczi K; Summers P; Aubert P; Cooper B; Meyerson H; Cooper KD; Honda K
    Am J Dermatopathol; 2008 Dec; 30(6):567-71. PubMed ID: 19033930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliative total skin electron beam therapy (TSEBT) for advanced cutaneous T-cell lymphoma.
    Funk A; Hensley F; Krempien R; Neuhof D; Van Kampen M; Treiber M; Roeder F; Timke C; Herfarth K; Helmbold P; Debus J; Bischof M
    Eur J Dermatol; 2008; 18(3):308-12. PubMed ID: 18474461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycosis fungoides--analysis of the duration of disease stages in patients who progress and the time point of high-grade transformation.
    Kamarashev J; Theler B; Dummer R; Burg G
    Int J Dermatol; 2007 Sep; 46(9):930-5. PubMed ID: 17822495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staging and management of cutaneous T-cell lymphoma.
    Scarisbrick JJ
    Clin Exp Dermatol; 2006 Mar; 31(2):181-6. PubMed ID: 16487086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation of cutaneous T cell lymphoma to large cell lymphoma. A clinicopathologic and immunologic study.
    Salhany KE; Cousar JB; Greer JP; Casey TT; Fields JP; Collins RD
    Am J Pathol; 1988 Aug; 132(2):265-77. PubMed ID: 3261136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staging laparotomy in cutaneous T-cell disease.
    Doyle JA; Winkelmann RK
    Arch Dermatol; 1981 Sep; 117(9):543-6. PubMed ID: 6457567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological profile in patients with non-Hodgkin's lymphomas.
    Urasiński I; Fiedorowicz-Fabrycy I; Sochacka-Kuzko B; Wichert K
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):467-74. PubMed ID: 6689470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.